What is Minerva Surgical's stock price target for 2024?

0 brokerages have issued 1 year target prices for Minerva Surgical's shares. Their UTRS share price targets range from $20.00 to $20.00. On average, they predict the company's share price to reach $20.00 in the next year. This suggests a possible upside of 3,821.6% from the stock's current price. View analysts price targets for UTRS or view top-rated stocks among Wall Street analysts .

How have UTRS shares performed in 2024?

Minerva Surgical's stock was trading at $1.17 at the beginning of 2024. Since then, UTRS stock has decreased by 56.4% and is now trading at $0.51. View the best growth stocks for 2024 here .

When is Minerva Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 30th 2024. View our UTRS earnings forecast .

How were Minerva Surgical's earnings last quarter?

Minerva Surgical, Inc. (NASDAQ:UTRS) issued its quarterly earnings results on Wednesday, December, 1st. The company reported ($23.00) earnings per share for the quarter, missing analysts' consensus estimates of ($8.80) by $14.20. The firm had revenue of $12.51 million for the quarter, compared to analyst estimates of $12.23 million. Minerva Surgical had a negative net margin of 64.71% and a negative trailing twelve-month return on equity of 136.40%.

When did Minerva Surgical's stock split?

Minerva Surgical shares reverse split on Monday, October 2nd 2023. The 1-20 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Minerva Surgical IPO?

Minerva Surgical (UTRS) raised $100 million in an initial public offering on Friday, October 22nd 2021. The company issued 6,250,000 shares at a price of $15.00-$17.00 per share.

How do I buy shares of Minerva Surgical?

Shares of UTRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:UTRS

Minerva Surgical (UTRS) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free UTRS Stock Alerts

$0.46

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.46
▼
$0.46
50-Day Range: $0.46
▼
$0.72
52-Week Range: $0.30
▼
$14.00

Volume: 7,330 shs
Average Volume: 1,064 shs
Market Capitalization: $4.08 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $20.00

Get Minerva Surgical alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Minerva Surgical Stock (NASDAQ:UTRS)

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

UTRS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

UTRS Stock News Headlines

April 18, 2024 | americanbankingnews.com

Minerva Surgical (NASDAQ:UTRS) Trading Down 8.9%

April 9, 2024 | americanbankingnews.com

Comparing CellaVision AB (publ) (OTCMKTS:CLVSF) & Minerva Surgical (NASDAQ:UTRS)

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

January 10, 2024 | thestreet.com

Minerva Surgical Inc.

December 18, 2023 | markets.businessinsider.com

Why Is Minerva Surgical (UTRS) Stock Down 50% Today?

December 17, 2023 | morningstar.com

Minerva Surgical Inc UTRS

November 14, 2023 | finanznachrichten.de

Minerva Surgical, Inc.: Minerva Surgical Reports Third Quarter 2023 Financial Results

November 14, 2023 | msn.com

Minerva Surgical GAAP EPS of -$0.81 misses by $0.27, revenue of $12M misses by $1.93M

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

November 13, 2023 | finance.yahoo.com

Minerva Surgical Reports Third Quarter 2023 Financial Results

September 29, 2023 | finance.yahoo.com

Accelmed Files Transaction Statement on Schedule 13E-3 with Securities and Exchange Commission

August 3, 2023 | finance.yahoo.com

Minerva Surgical Reports Second Quarter 2023 Financial Results

August 3, 2023 | finance.yahoo.com

Minerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue Estimates

May 25, 2023 | finance.yahoo.com

Investors in Minerva Surgical (NASDAQ:UTRS) from a year ago are still down 86%, even after 51% gain this past week

May 24, 2023 | msn.com

Why Minerva Surgical Shares Are Taking Off Wednesday

May 24, 2023 | theglobeandmail.com

Patent Grant Sends Healthcare Shares Soaring Premarket

May 24, 2023 | msn.com

Why Is Minerva Surgical (UTRS) Stock Up 229% Today?

May 3, 2023 | finance.yahoo.com

Q1 2023 Minerva Surgical Inc Earnings Call

May 2, 2023 | finance.yahoo.com

Minerva Surgical Reports First Quarter 2023 Financial Results

April 18, 2023 | finance.yahoo.com

Minerva Surgical to Announce First Quarter 2023 Financial Results

March 24, 2023 | finance.yahoo.com

Minerva Surgical, Inc. (NASDAQ:UTRS) Q4 2022 Earnings Call Transcript

March 23, 2023 | markets.businessinsider.com

Piper Sandler Remains a Buy on Minerva Surgical (UTRS)

March 22, 2023 | benzinga.com

Minerva Surgical Stock (NASDAQ:UTRS), Dividends

March 22, 2023 | finanznachrichten.de

Minerva Surgical, Inc.: Minerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial Results

March 22, 2023 | finance.yahoo.com

Q4 2022 Minerva Surgical Inc Earnings Call

March 21, 2023 | finance.yahoo.com

Minerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial Results

March 21, 2023 | finance.yahoo.com

Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial Officer

See More Headlines

Receive UTRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Minerva Surgical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 12/01/2021
Today: 4/19/2024
Next Earnings (Estimated): 4/30/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:UTRS
CUSIP: N/A
CIK: 1452965
Web: www.minervasurgical.com
Phone: 855-646-7874
Fax: N/A
Employees: 174
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $20.00
High Stock Price Target: $20.00
Low Stock Price Target: $20.00
Potential Upside/Downside: +4,247.8%
Consensus Rating
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($8.21)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-34,110,000.00
Net Margins: -64.71%
Pretax Margin: -64.61%
Return on Equity: -136.40%
Return on Assets: -43.70%

Debt

Debt-to-Equity Ratio: 1.38
Current Ratio: 1.88
Quick Ratio: 1.03

Sales & Book Value

Annual Sales: $50.29 million
Price / Sales: 0.08
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $11.52 per share
Price / Book: 0.04

Miscellaneous

Outstanding Shares: 8,880,000
Free Float: 8,124,000
Market Cap: $4.08 million
Optionable: Not Optionable
Beta: 0.67

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. Joel R. Jung MBA (Age 66)
Chief Financial Officer
Comp: $400.6k
Mr. Dominique J. Filloux (Age 61)
Chief Operating Officer
Comp: $390k
Mr. Todd Usen (Age 57)
President, CEO & Director
Ms. Wendy Bowman
Vice President of Human Resources
Dr. Evgueni V. Skalnyi M.D. (Age 58)
Chief Medical Officer
Comp: $365.25k
Ms. Kaile Zagger
Chief Commercial Officer
Ms. Joanne Long
Vice President of Corporate Controller

Key Competitors

View All Competitors

UTRS Stock Analysis - Frequently Asked Questions

What is Minerva Surgical's stock price target for 2024?: 0 brokerages have issued 1 year target prices for Minerva Surgical's shares. Their UTRS share price targets range from $20.00 to $20.00. On average, they predict the company's share price to reach $20.00 in the next year. This suggests a possible upside of 3,821.6% from the stock's current price.
View analysts price targets for UTRS or view top-rated stocks among Wall Street analysts.
How have UTRS shares performed in 2024?: Minerva Surgical's stock was trading at $1.17 at the beginning of 2024. Since then, UTRS stock has decreased by 56.4% and is now trading at $0.51.
View the best growth stocks for 2024 here.
When is Minerva Surgical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 30th 2024.
View our UTRS earnings forecast.
How were Minerva Surgical's earnings last quarter?: Minerva Surgical, Inc. (NASDAQ:UTRS) issued its quarterly earnings results on Wednesday, December, 1st. The company reported ($23.00) earnings per share for the quarter, missing analysts' consensus estimates of ($8.80) by $14.20. The firm had revenue of $12.51 million for the quarter, compared to analyst estimates of $12.23 million. Minerva Surgical had a negative net margin of 64.71% and a negative trailing twelve-month return on equity of 136.40%.

When did Minerva Surgical's stock split?: Minerva Surgical shares reverse split on Monday, October 2nd 2023. The 1-20 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
When did Minerva Surgical IPO?: Minerva Surgical (UTRS) raised $100 million in an initial public offering on Friday, October 22nd 2021. The company issued 6,250,000 shares at a price of $15.00-$17.00 per share.
How do I buy shares of Minerva Surgical?: Shares of UTRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:UTRS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial